Internal Medicine, Medical Oncology · Stanford, CA
NPI
1982994802
Since 2011
Specialty
Internal Medicine, Medical Oncology
Code 207RX0202X
Group practices
2
Medicare group memberships
Hospitals
2
Hospital affiliations
300 Pasteur Dr
Stanford, CA, 94305
Phone (650) 723-4000
Groups this clinician bills Medicare through
Medicare paid, 2024
$77K
603 services
Medicare patients, 2024
197
Average age 72
Drug cost, 2024
$2.7M
630 prescriptions
Company payments, 2025
$1,354
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Nam Q Bui was code 99215 (office e&m - established), 194 times for 60 patients. In total Nam Q Bui billed 603 services in 11 codes, and Medicare paid $77K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-04-16.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Office | 194 | 60 | $166.22 | $32K |
| 99214 Office E&M - Established | Office | 131 | 67 | $116.09 | $15K |
| 99213 Office E&M - Established | Office | 110 | 72 | $81.23 | $8,936 |
| 99215 Office E&M - Established | Facility | 48 | 21 | $125.95 | $6,045 |
| 99205 Office E&M - New | Office | 24 | 24 | $200.01 | $4,800 |
| 99223 Hospital E&M - Initial | Facility | 24 | 24 | $155.55 | $3,733 |
| 99233 Hospital E&M - Subsequent | Facility | 16 | 11 | $106.45 | $1,703 |
| 99214 Office E&M - Established | Facility | 15 | 12 | $81.98 | $1,230 |
| 99213 Office E&M - Established | Facility | 15 | 11 | $42.59 | $639 |
| 99205 Office E&M - New | Facility | 11 | 11 | $163.22 | $1,795 |
By year: 2022 $54K for 467 services; 2023 $61K for 562 services; 2024 $77K for 603 services.
Medicare prescription drug claims, 2024
In 2024, the drug Nam Q Bui prescribed most often to Medicare patients was Imatinib Mesylate, with 80 prescriptions and refills. In total Nam Q Bui wrote 630 Medicare prescriptions that cost $2.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Imatinib Mesylate Generic | 80 | 82 | 14 | $11K |
| Ondansetron Hcl Generic | 63 | 63 | 18 | $510 |
| Eliquis Apixaban | 46 | 52 | Under 11 | $28K |
| Ibrance Palbociclib | 35 | 35 | Under 11 | $533K |
| Prednisone Generic | 26 | 30 | 12 | $90.4 |
| Oxycodone Hcl Generic | 23 | 23 | Under 11 | $162 |
| Sunitinib Malate Generic | 23 | 23 | Under 11 | $141K |
| Pazopanib Hcl Generic | 22 | 22 | Under 11 | $205K |
| Prochlorperazine Maleate Generic | 21 | 21 | Under 11 | $148 |
| Lorazepam Generic | 18 | 18 | Under 11 | $58.67 |
| Dexamethasone Generic | 15 | 15 | Under 11 | $328 |
| Pantoprazole Sodium Generic | 14 | 20 | Under 11 | $219 |
| Cabometyx Cabozantinib S-Malate | 14 | 14 | Under 11 | $324K |
| Xalkori Crizotinib | 12 | 12 | Under 11 | $274K |
| Vitrakvi Larotrectinib Sulfate | 12 | 12 | Under 11 | $465K |
Brand drugs: 169 claims; generic drugs: 461 claims; opioid claims: 46.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Nam Q Bui $1,354 ($1,354 in general payments such as food, travel and fees) from 2 companies. The largest payer was Deciphera Pharmaceuticals Inc. with $1,354.
| Company | Payments | Amount |
|---|---|---|
| Deciphera Pharmaceuticals Inc. | 3 | $1,354 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.